Alzheimer-like hyperphosphorylation of tau in brains of rats with obesity and type 2 diabetes

Progress in Biochemistry and Biophysics

Volumn 33, Issue 5, 2006, Pages 458-464

  Yang, Yan ^a   Hu, Shu Hong ^a   Zhang, Jian Hua ^a   Zhang, Mu Xun ^a   Gong, Cheng Xin ^b,c  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Alzheimer disease; Glycogen synthase kinase 3 ; Hyperphosphorylation; Insulin resistance; Tau protein

Indexed keywords

EID: 33746303414     PISSN: 10003282     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Higuchi M, Iwata N, Saido T C. Understanding molecular mechanisms of proteolysis in Alzheimer's disease: progress toward therapeutic interventions. Biochim Biophys Acta, 2005, 1751(1): 60-67
2. Iqbal K, Alonso Adel C, Chen S, et al. Tau pathology in Alzheimer disease and other tauopathies. Biochim Biophys Acta, 2005, 1739 (2-3): 198-210
3. Xu W L, Qiu C X, Wahlin A, et al. Diabetes mellitus and the risk of dementia in the Kungsholmen project: a 6-years follow-up study. Neurology, 2004, 63 (7): 1181-1186
4. Arvanitakis Z, Wilson R S, Bienias J L, et al. Diabetes mellitus and the risk of Alzheimer disease and decline in congnitive function. Arch Neurol, 2004, 61 (5): 661-666
5. Hong M, Lee V M Y. Insulin and insulin-like growth factor-1 regulate tau phosphorylation in cultured human neurons. J Biol Chem, 1997, 272 (31): 19547-19553
6. Steen E, Terry B M, Rivral E J, et al. Impaired insulin and insulin-like growth factor expreecion and signaling mechanisms in Alzheimer's disease- is this type 3 diabetes?. J Alzheimers Dis, 2005,7 (1): 63-80
7. Blass J P, Gibson G E, Hoyer S. The role of the metabolic lesion in Alzheimer's disease. J Alzheimers Dis, 2002, 4 (3): 225-232
8. Bao X M, Shu S Y. Stereotaxic Atlas of Rat Brain. Beijing: People Health Press, 1991. 47-50
9. Matthews D R, Hosker J P, Rudenski A S, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 1985, 28 (7):412-419
10. Daly N L, Hoffmann R, Otvos L, et al. Role of phosphorylation in the conformation of tau peptides implicated in Alzheimer's disease. Biochemistry, 2000, 39 (30): 9039-9046
11. Gong C X, Liu F, Grundke-Iqbal I, et al. Post-translational modifications of tau protein in Alzheimer's disease. J Neural Transm, 2005, 112 (6): 813-838
12. Li X J. Insulin Resistance Syndrome. Beijing: People Health Press, 2001. 22-43
13. Liu F, Iqbal K, Grundke-Iqbal I, et al. O-GlcNAcylation regulates phosphorylation of tau: A mechanism involved in Alzheimer's disease. Proc Natl Acad Sci USA, 2004, 101 (29): 10804-10809
14. McEwen B S, Reagan L P. Glucose transporter expression in the central nervous system: relationship to synaptic function. Eur J Pharmacol, 2004, 490 (1-3): 13-24